Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/9/2026

PPD Screening for Tuberculosis

Procedure for PPD Administration

  • The Centers for Disease Control and Prevention recommends the Mantoux technique for administering the PPD test, involving the intracutaneous injection of 0.1 mL of PPD (5 tuberculin units) just beneath the skin surface on the volar or dorsal forearm 1, 2
  • A proper injection should produce a pale elevation of the skin (wheal) measuring 6-10 mm in diameter, as stated by the Centers for Disease Control and Prevention 1, 3
  • The test must be read by trained healthcare personnel between 48 and 72 hours after injection, according to the Centers for Disease Control and Prevention 1, 3
  • The reading measures only the induration (hardened area) at the injection site in millimeters, not the erythema (redness), as recommended by the Centers for Disease Control and Prevention 1, 2

Interpretation of Results

  • For high-risk individuals, the Centers for Disease Control and Prevention considers ≥5 mm induration as a positive result 1, 3, 4
  • For moderate-risk individuals, the Centers for Disease Control and Prevention considers ≥10 mm induration as a positive result 1, 3
  • For low-risk individuals with no known risk factors, the Centers for Disease Control and Prevention considers ≥15 mm induration as a positive result 1, 3

Clinical Applications

  • The primary purpose of PPD testing is to identify individuals with latent tuberculosis infection who may benefit from preventive therapy, as stated by the American College of Rheumatology and the Centers for Disease Control and Prevention 4, 5
  • PPD testing is particularly important for screening high-risk populations such as healthcare workers, correctional facility residents, and immunocompromised patients, according to the Centers for Disease Control and Prevention 6, 7
  • For healthcare workers, baseline PPD testing should be performed during pre-employment physical examinations, with the two-step method recommended for those without documented negative PPD in the preceding 12 months, as recommended by the Centers for Disease Control and Prevention 6, 7
  • PPD testing should be followed by chest radiography and clinical evaluation in individuals with positive results to exclude active tuberculosis, as stated by the Centers for Disease Control and Prevention and the American College of Radiology 4, 8

Follow-up Actions Based on Results

  • Negative PPD test: No further treatment required if the test is valid, according to the American College of Rheumatology 5
  • Positive PPD test without evidence of active TB: Preventive therapy with isoniazid (INH) for 9-12 months is recommended, particularly for HIV-infected individuals, as stated by the American College of Rheumatology and the Centers for Disease Control and Prevention 4, 5
  • Positive PPD test with suspicious symptoms or abnormal chest radiograph: Further evaluation for active TB is required, including sputum examination, according to the Centers for Disease Control and Prevention and the American College of Radiology 8, 9

Special Considerations

  • The two-step testing method may be necessary for baseline testing to detect boosting phenomena that might be misinterpreted as a skin test conversion, as recommended by the Centers for Disease Control and Prevention 6, 7
  • Previous BCG vaccination can cause false-positive PPD results, but this should not prevent PPD testing in individuals who need screening, according to the American College of Rheumatology and the Centers for Disease Control and Prevention 5, 6

Common Pitfalls and Caveats

  • Improper administration technique can lead to false-negative results, as stated by the Centers for Disease Control and Prevention 1, 3
  • Reading the test outside the recommended 48-72 hour window reduces accuracy, according to the Centers for Disease Control and Prevention 1, 2
  • Measuring erythema instead of induration leads to incorrect interpretation, as recommended by the Centers for Disease Control and Prevention 1, 3
  • Failure to consider risk factors when interpreting results can lead to inappropriate clinical decisions, according to the Centers for Disease Control and Prevention 1, 3
  • Relying on patient self-reading of results is unreliable and not recommended, as stated by the Centers for Disease Control and Prevention 1, 2

Tuberculosis Screening with the PPD Two-Step Process

Purpose and Procedure

  • The two-step PPD testing process is specifically designed to detect the booster phenomenon in individuals with waned TB infection, preventing misinterpretation of boosted reactions as new infections during subsequent serial testing, as recommended by the American Thoracic Society and the Centers for Disease Control and Prevention 10, 11
  • The two-step PPD testing method addresses the "booster effect" phenomenon, where individuals previously infected with TB may have a diminished ability to react to tuberculin that can be restored by an initial PPD test, according to the American Journal of Respiratory and Critical Care Medicine 10
  • Without two-step testing, a boosted reaction on subsequent testing might be misinterpreted as a new infection (conversion), leading to unnecessary contact investigations and preventive therapy, as noted by the Centers for Disease Control and Prevention 11, 12

Clinical Applications

  • Two-step testing should be performed on all newly employed healthcare workers who have an initial negative PPD test and no documented negative PPD test within the preceding 12 months, as recommended by the Centers for Disease Control and Prevention 11, 12
  • It is particularly important in settings where periodic TB screening is conducted, such as healthcare facilities, correctional institutions, and nursing homes, according to the Centers for Disease Control and Prevention 13
  • The process is valuable for establishing baseline TB status in populations with high rates of prior TB exposure or BCG vaccination, as noted by the American Thoracic Society 10

Special Considerations

  • The booster phenomenon is more common in older adults but can occur in any age group, according to the Centers for Disease Control and Prevention 11, 12
  • Boosted reactions are particularly common in individuals previously vaccinated with BCG or exposed to nontuberculous mycobacteria, as noted by the American Thoracic Society 10
  • The boosting effect can occur years after the initial infection or BCG vaccination, according to the American Thoracic Society and the Centers for Disease Control and Prevention 10, 12

Common Pitfalls and Caveats

  • Failure to implement two-step testing in appropriate populations can lead to misclassification of boosted reactions as new infections, as noted by the Centers for Disease Control and Prevention 11, 12
  • Improper timing between the first and second test (should be 1-3 weeks) may affect the accuracy of detecting the booster phenomenon, according to the American Thoracic Society and the Centers for Disease Control and Prevention 10, 11

Tuberculin Skin Test Administration and Interpretation Guidelines

Proper Timing and Administration

  • When a second TB skin test is needed, it should be administered 1-3 weeks after the first test, according to the Pediatrics guideline, to allow for accurate interpretation 14
  • Performing a second test too soon can interfere with the immunological response and lead to inaccurate results, as reported by MMWR Recommendations and Reports 15, 16

Special Considerations

  • The booster phenomenon is more common in individuals with previous BCG vaccination, older adults, and foreign-born persons from high TB prevalence countries, as noted by MMWR Recommendations and Reports 16
  • For contacts of persons with infectious TB, a negative test result obtained less than 8 weeks after exposure is considered unreliable, and follow-up testing at 8-10 weeks after exposure ends is recommended by MMWR Recommendations and Reports 16, 17

Alternative Testing Approaches

  • For individuals who cannot return for TST reading within the proper timeframe, interferon-gamma release assays (IGRAs) may be considered as they require only a single visit, according to Clinical Infectious Diseases 18
  • In certain high-risk populations, dual testing with both TST and IGRA may be appropriate to increase sensitivity, as suggested by Clinical Infectious Diseases 18

Two-Step PPD Test Timing

Standard Two-Step Protocol

  • The American Thoracic Society recommends placing the first PPD test on Day 0, and reading it on Day 2-3 (48-72 hours) 19, 20, 21
  • The second PPD test should be placed 1-3 weeks after the reading of the first test, which is approximately Day 9-24, and read 48-72 hours later 19, 20

Common Pitfalls to Avoid

  • The American College of Chest Physicians recommends that tests must be read at 48-72 hours, and readings outside this window reduce accuracy, and only measure induration (hardened area), not redness 19, 20

Two‑Step Tuberculin Skin Test Guidelines

Booster Phenomenon and At‑Risk Populations

  • The booster effect may appear years after initial TB infection or BCG vaccination, especially among older adults, individuals born in high‑TB‑prevalence countries, and those previously vaccinated with BCG, indicating the need for two‑step testing to avoid misinterpreting boosted reactions as new infection. 22 (CDC)

Timing for Post‑Exposure Testing

  • In contact investigations, the optimal window to detect a new TB infection is 8–10 weeks after the end of exposure; a negative tuberculin skin test performed less than 8 weeks after exposure is considered unreliable. 22 (CDC)

Common Pitfalls

  • Confusing baseline two‑step testing with post‑exposure testing can lead to inappropriate timing and misclassification of results, as the two approaches serve distinct purposes and have different timing requirements. 22 (CDC)

REFERENCES

← Return to Home